Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
32.3M
-
Shares change
-
+426K
-
Total reported value, excl. options
-
$995M
-
Value change
-
+$13.4M
-
Put/Call ratio
-
0.31
-
Number of buys
-
81
-
Number of sells
-
-77
-
Price
-
$30.82
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2016
204 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q4 2016.
REPLIGEN CORP - COMMON STOCK (RGEN) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.3M shares
of 56.2M outstanding shares and own 57.39% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (3.08M shares), OppenheimerFunds, Inc. (1.94M shares), VANGUARD GROUP INC (1.69M shares), Invesco Ltd. (1.67M shares), TimesSquare Capital Management, LLC (1.46M shares), FMR LLC (1.3M shares), Conestoga Capital Advisors, LLC (1.12M shares), STATE STREET CORP (1.06M shares), BlackRock Institutional Trust Company, N.A. (975K shares), and DIMENSIONAL FUND ADVISORS LP (975K shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.